More rigorous protocol adherence to intensive structured management improves blood pressure control in primary care: Results from the Valsartan Intensified Primary carE Reduction of Blood Pressure study

Journal of Hypertension

Volumn 32, Issue 6, 2014, Pages 1342-1350

  Stewart, Simon ^a   Stocks, Nigel P ^b   Burrell, Louise M ^c   De Looze, Ferdinandus J ^d   Esterman, Adrian ^e   Harris, Mark ^f   Hung, Joseph ^g   Swemmer, Carla H ^h   Kurstjens, Nicol P ^h   Jennings, Garry L ^a   Carrington, Melinda J ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

^g UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^h Novartis Pharmaceuticals Australia Ltd   (Australia)

Author keywords

antihypertensive treatment; blood pressure; cardiovascular disease; hypertension; management; primary care; treatment targets

Indexed keywords

AMLODIPINE; HYDROCHLOROTHIAZIDE PLUS VALSARTAN; VALSARTAN; ANTIHYPERTENSIVE AGENT; TETRAZOLE DERIVATIVE; VALINE;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DRUG DOSE TITRATION; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT COMPLIANCE; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTOCOL COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TREATMENT DURATION; AGED; ANALOGS AND DERIVATIVES; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CLINICAL TRIAL; DRUG EFFECTS; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PRIMARY HEALTH CARE; TIME; TREATMENT OUTCOME;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; TETRAZOLES; TIME FACTORS; TREATMENT OUTCOME; VALINE;

EID: 84900439398     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000180     Document Type: Article

References (27)

1. He FJ, MacGregor GA. Blood pressure is the most important cause of death and disability in the world. Eur Heart J Suppl 2007; 9 (Supp B):B23-B28.
2. Yang Q, Cogswell ME, Flanders WD, Hong Y, Zhang Z, Loustalot F, et al. Trends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adults. JAMA 2012; 307:1273-1283.
3. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemio-logical studies. BMJ 2009; 338:b1665.
4. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013; 34:2159-2219.
5. Carrington MJ, Jennings GL, Stewart S. Pattern of blood pressure in Australian adults: results from a national blood pressure screening day of 13 825 adults. Int J Cardiol 2010; 145:461-467.
6. Carrington MJ, Jennings GL, Stewart S. Pressure points in primary care: blood pressure and management of hypertension in 532 050 patients from 2005 to 2010. J Hypertens 2013; 31:1265-1271.
7. Ernst ME. Resistant hypertension or resistant prescribing? Hypertension 2011; 58:987-988.
8. Britt H, Miller G, Henderson J, Charles J, Valenti L, Harrison C, et al. General practice activity in Australia 2011-2012. Sydney: Sydney University Press; 2012.
9. Clark CE, Smith LF, Taylor RS, Campbell JL. Nurse led interventions to improve control of blood pressure in people with hypertension: systematic review and meta-analysis. BMJ 2010; 341:c3995.
10. Glynn LG, Murphy AW, Smith SM, Schroeder K, Fahey T. Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database Syst Rev 2010;CD005182
11. Australian Medicare local Alliance. 2012 General Practice Nurse National Survey Report; 2012. http://amlalliance.com.au/medicare-local-support/nigp. [Accessed 20 August 2013].
12. Stewart S, Carrington MJ, Swemmer CH, Anderson C, Kurstjens NP, Amerena J, et al. Effect of intensive structured care on individual blood pressure targets in primary care: multicentre randomised controlled trial. BMJ 2012; 345:e7156.
13. Stewart S, Carrington MJ, Swemmer C, Kurstjens N, Jennings GL. Optimising management of hypertension in primary care: the Valsartan Intensified Primary Care Reduction of Blood Pressure (VIPER-BP) study. Int J Cardiol 2011; 153:317-322.
14. National Heart Foundation of Australia (National Blood Pressure and Vascular Disease Advisory Committee). Guide to Management of Hypertension, 2008. Updated December 2010. http://www.heartfoun-dation.org.au/information-for- professionals/Clinical-Information/Pages/hypertension.aspx. [Accessed 20 August 2013].
15. Zwarenstein M, Treweek S, Gagnier JJ, Altman DG, Tunis S, Haynes B, et al. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ 2008; 337:a2390.
16. National Vascular Disease Prevention Alliance. Guidelines for the assessment of absolute cardiovascular disease risk: National Heart Foundation of Australia; 2009. http://www.heartfoundation.org.au/information-for- professionals/Clinical-Information/Pages/absolute-risk. aspx. [Accessed 20 August 2013].
17. Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profiles. Am Heart J 1991; 121:293-298.
18. Arroll B, Khin N, Kerse N. Screening for depressionin primary care with two verbally asked questions: cross sectional study. BMJ 2003; 327: 1144-1146.
19. Corrao G, Parodi A, Zambon A, Heiman F, Filippi A, Cricelli C, et al. Reduced discontinuation of antihypertensive treatment by two-drug combination as first step. Evidence from daily life practice. J Hypertens 2010; 28:1584-1590.
20. Phillips CB, Pearce C, Hall S, Kljakovic M, Sibbald B, Dwan K, et al. Enhancing care, improving quality: the six roles of the general practice nurse. Med J Aust 2009; 191:92-97.
21. McAlister FA, Stewart S, Ferrua S, McMurray JJ. Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. J Am Coll Cardiol 2004; 44:810-819.
22. Stewart S, Carrington MJ, Marwick TH, Davidson PM, Macdonald P, Horowitz JD, et al. Impact of home versus clinic-based management of chronic heart failure: the WHICH? (Which Heart Failure Intervention Is Most Cost-Effective & Consumer Friendly in Reducing Hospital Care) multicenter, randomized trial. J Am Coll Cardiol 2012; 60:1239-1248.
23. Stewart S, Carrington MJ, Swemmer CH, Kurstjens NP, Brown A, Burrell LM, et al. Determinants of achieving early blood pressure control with monotherapy in a primary care setting. J Clin Hypertens (Greenwich) 2013; 15:674-680.
24. Holt E, Joyce C, Dornelles A, Morisky D, Webber LS, Muntner P, et al. Sex differences in barriers to antihypertensive medication adherence: findings from the cohort study of medication adherence among older adults. J Am Geriatr Soc 2013; 61:558-564.
25. Carlsson AC, Wandell P, Osby U, Zarrinkoub R, Wettermark B, Ljunggren G. High prevalence of diagnosis of diabetes, depression, anxiety, hypertension, asthma and COPD in the total population of Stockholm, Sweden: a challenge for public health. BMC Public Health 2013; 13:670.
26. Lambert E, Sari CI, Dawood T, Nguyen J, McGrane M, Eikelis N, et al. Sympathetic nervous system activity is associated with obesity-induced subclinical organ damage in young adults. Hypertension 2010; 56:351-358.
27. Feldman RD, Zou GY, Vandervoort MK, Wong CJ, Nelson SA, Feagan BG. A simplified approach to the treatment of uncomplicated hypertension: a cluster randomized, controlled trial. Hypertension 2009; 53:646-653.